Rami Alzhrani
Rami Alzhrani
Faculty of Pharmaceutics and Industrial Pharmacy, Taif University, Saudi Arabia
Verified email at tu.edu.sa
Cited by
Cited by
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers in pharmacology 8, 561, 2017
Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
S Sau, HO Alsaab, K Bhise, R Alzhrani, G Nabil, AK Iyer
Journal of Controlled Release 274, 24-34, 2018
Comparison of electrospun and solvent cast polylactic acid (PLA)/poly (vinyl alcohol)(PVA) inserts as potential ocular drug delivery vehicles
RS Bhattarai, A Das, RM Alzhrani, D Kang, SB Bhaduri, SHS Boddu
Materials Science and Engineering: C 77, 895-903, 2017
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages
HO Alsaab, S Sau, RM Alzhrani, VT Cheriyan, LA Polin, U Vaishampayan, ...
Biomaterials 183, 280-294, 2018
Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma
H Alsaab, RM Alzhrani, P Kesharwani, S Sau, SHS Boddu, AK Iyer
Pharmaceutics 9 (2), 15, 2017
Development and evaluation of a novel microemulsion of dexamethasone and tobramycin for topical ocular administration
RD Bachu, M Stepanski, RM Alzhrani, R Jung, SHS Boddu
Journal of ocular pharmacology and therapeutics 34 (4), 312-324, 2018
Formulation and In Vitro Evaluation of Cyclosporine-A Inserts Prepared Using Hydroxypropyl Methylcellulose for Treating Dry Eye Disease
ZHF Al-Saedi, RM Alzhrani, SHS Boddu
Journal of Ocular Pharmacology and Therapeutics 32 (7), 451-462, 2016
Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems
R Alzhrani, HO Alsaab, A Petrovici, K Bhise, K Vanamala, S Sau, ...
Drug discovery today 25 (4), 718-730, 2020
Evaluation of the percutaneous absorption of chlorpromazine from PLO gels across porcine ear and human abdominal skin
H Alsaab, RM Alzhrani, SHS Boddu
Drug development and industrial pharmacy 42 (8), 1258-1266, 2016
Progress in clinical trials of photodynamic therapy for solid tumors and the role of nanomedicine
HO Alsaab, MS Alghamdi, AS Alotaibi, R Alzhrani, F Alwuthaynani, ...
Cancers 12 (10), 2793, 2020
Tanshinone IIA inhibits VEGF secretion and HIF-1α expression in cultured human retinal pigment epithelial cells under hypoxia
RM Alzhrani, Q Alhadidi, RD Bachu, Z Shah, S Dey, SHS Boddu
Current eye research 42 (12), 1667-1673, 2017
Nanomaterials for tumor immunomodulation and overcoming current clinical challenges
S Sau, R Alzhrani, K Bhise, HO Alsaab, SK Kashaw, AK Iyer
Nanomedicine 14 (12), 1515-1519, 2019
Cytotoxicity of inhalable dry powders in A459 human lung cancer cell line
A Chvatal, R Alzhrani, AK Tiwari, R Ambrus, P Révész, SHS Boddu
FARMACIA (BUCHAREST) 66 (1), 172-175, 2018
Imaging tools to enhance animal tumor models for cancer research and drug discovery
HO Alsaab, R Alzhrani, AH Almalki, YS Althobaiti, S Sau, AK Iyer
Animal Models in Cancer Drug Discovery, 75-106, 2019
CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer. Cancers 2021, 13, 898
G Nabil, R Alzhrani, HO Alsaab, M Atef, S Sau, AK Iyer, HE Banna
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer
G Nabil, R Alzhrani, HO Alsaab, M Atef, S Sau, AK Iyer, HE Banna
Cancers 13 (4), 898, 2021
Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine
HO Alsaab, AS Al-Hibs, R Alzhrani, KK Alrabighi, A Alqathama, ...
International Journal of Molecular Sciences 22 (4), 1631, 2021
Nanoparticle pro-drug to overcome the stromal barrier in pancreatic ductal adenocarcinoma Rami Alzhrani
R Alzhrani, S Sau, A Aboukameel, HO Alsaab, AS Azmi, AK Iyer
Ultra‐Small Biomimetic Nanoparticles for Alzheimer’s Disease Targeted Drug Delivery
K Tatiparti, MA Rauf, S Sau, R Alzhrani, A Iyer
The FASEB Journal 34 (S1), 1-1, 2020
Hypoxia Targeting Nanoparticles for Immunogenic Cell Death of Triple Negative Breast Cancer
K Bhise, S Sau, MA Rauf, R Alzhrani, A Iyer
The FASEB Journal 34 (S1), 1-1, 2020
The system can't perform the operation now. Try again later.
Articles 1–20